FDA's Overreach on Compounded Peptides BREAKING: The FDA just made it official. Advisory committee meetings are now scheduled for July 23 24 to review reclassifying peptides back to legal compounding status. Here's what's happening: After the Regulatory Updates on Compounded Peptides New Drug Loft and VLS Pharmacy FDA Moves to Reevaluate Several Peptides American Med Spa Association Peptides, Drugs And Supplements: Science, Risks, And Alternatives Los Angeles Times FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures Pittsburgh Post Gazette